| Product Code: ETC11944654 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Industry Life Cycle |
3.4 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Porter's Five Forces |
3.5 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.7 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
4 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of obesity, type II diabetes, and NAFLD (Non-Alcoholic Fatty Liver Disease) in Canada |
4.2.2 Growing awareness about the benefits of endoscopic procedures for treating obesity, type II diabetes, and NAFLD |
4.2.3 Technological advancements in endoscopy devices leading to improved efficacy and safety in procedures |
4.3 Market Restraints |
4.3.1 High cost associated with endoscopic procedures and devices |
4.3.2 Limited reimbursement policies for endoscopic treatments in Canada |
4.3.3 Regulatory challenges and approval processes for new endoscopy devices |
5 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Trends |
6 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Types |
6.1 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Product, 2021 - 2031F |
6.1.3 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Endoscope, 2021 - 2031F |
6.1.4 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Mechanical endoscopic equipment, 2021 - 2031F |
6.1.5 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Visualization and documentation systems, 2021 - 2031F |
6.1.6 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Accessories, 2021 - 2031F |
6.1.7 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Other endoscopy equipment , 2021 - 2031F |
6.2 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Gastric balloon, 2021 - 2031F |
6.2.3 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Aspiration therapy, 2021 - 2031F |
6.2.4 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Endoscopic sleeve gastroplasty, 2021 - 2031F |
6.2.5 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Gastric injection, 2021 - 2031F |
6.2.6 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Lap band surgery , 2021 - 2031F |
6.3 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Obesity , 2021 - 2031F |
6.3.3 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Type II Diabetes , 2021 - 2031F |
6.3.4 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Nonalcoholic Steatohepatitis (NASH, 2021 - 2031F |
7 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Import-Export Trade Statistics |
7.1 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Export to Major Countries |
7.2 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Imports from Major Countries |
8 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Key Performance Indicators |
8.1 Patient outcomes improvement rate post-endoscopic procedures |
8.2 Adoption rate of endoscopic devices for obesity, type II diabetes, and NAFLD treatments |
8.3 Number of clinical trials or studies supporting the effectiveness of endoscopic procedures for these conditions |
9 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Opportunity Assessment |
9.1 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.3 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Competitive Landscape |
10.1 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenue Share, By Companies, 2024 |
10.2 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here